Under the agreement, the companies will create a workflow integrating NanoString's GeoMx Digital Spatial Profiling instrument with Leica's Bond RX autostainer.
The deal covers genomic test development services including assay and bioinformatics design assistance and revenue cycle management optimization.
The data analysis pipeline will allow users to pre-process raw InDrop single-cell RNA-seq data and use Partek tools to characterize single cells.
Test volume for the firm's Cologuard colorectal cancer screening test rose 49 percent year over year during the quarter.
The companies will comarket Ultivue's UltiMapper assays with Leica's Bond Rx research staining platform for research applications.
The companies will integrate Fabric's Enterprise NGS data analysis, interpretation, and clinical reporting platform with Genomenon's literature search engine.
The companies will jointly promote Visiopharm's Phenomap image-analysis software alongside Fluidigm's Hyperion imaging system and related products.
The companies will combine GenomOncology's GO Immuno-Oncology Workbench analysis software with Fluidigm's Advanta IO Gene Expression Assay.
Pfizer will join Exact's sales reps to increase adoption of the colorectal cancer test; Wall Street reacted by sending Exact's shares up sharply.
The collaboration will make use of Fluidigm's automated microfluidic systems to accelerate the design of panels for translational and clinical researchers.
Bloomberg reports that the DNA-for-cash deal reported in Kentucky might be a more widespread scam.
St. Jude Children's Research Hospital scientists have treated infants with X-linked severe combined immunodeficiency using gene therapy in an early phase study.
St. Louis Public Radio reports that some African Americans are turning to DNA ancestry testing to help guide genealogical searches.
In Nature this week: a genomic analysis of the snailfish Pseudoliparis swirei, ancient DNA analysis gives insight into the introduction of farming to England, and more.